Biologics and Biosimilars Treatment for Psoriasis in US 2017 Market Outlook, Research, Trends and Forecast to 2022
The U.S. psoriasis treatment market for Biologics and Biosimilars was estimated at $6.6bn in 2016 is projected to almost double during the forecast period to reach $12.9bn in 2021 driven by safety and efficacy improvements of the new generation biologics.
View full press release